产品
编 号:F195915
分子式:C31H29ClN6O3S
分子量:601.12
产品类型
结构图
CAS No: 1630086-20-2
联系客服
产品详情
生物活性:
Kira8 (AMG-18) is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity with an IC50 of 5.9 nM.
体内研究:
Male Ins2+/Akita mice are injected i.p. with KIRA8 (50 mg/kg; daily; for 35 days), significant reduction of hyperglycemia become apparent over several weeks. ?One week treatment of pre-diabetic NODs mice with Kira8 (50 mg/kg; i.p.; once a day) leads to significant reductions in islet XBP1 splicing and TXNIP mRNAs, and preserves Ins1/Ins2, BiP and MANF mRNAs.Animal Model:Male Ins2+/Akita mice
Dosage:50 mg/kg
Administration:Injected i.p.; daily; for 35 days
Result:Significant reduction of hyperglycemia became apparent over several weeks.
体外研究:
Kira8 blocks IRE1α oligomerization, and potently inhibits IRE1α RNase activity against XBP1 and Ins2 RNAs. Kira8 more potently reduces IRE1α-driven apoptosis in INS-1 cells than KIRA6 and also reverses XBP1 splicing promoted by GNF-2.